Moderna Cancer Vaccine Cuts Melanoma Return Risk by Half

A personalized cancer vaccine from Moderna and Merck just proved it can train your immune system to fight melanoma tumors with pinpoint accuracy.

Thousands of patients could benefit within years, with trials already underway for lung, pancreatic, and colon cancers.